Surgery Imaging News
-
Synaptive Medical Receives FDA 510(k) Clearance for Near-Infrared Fluorescence Visualization, Expanding Application of Existing Robotic Exoscope
Near-Infrared fluorescence now available on Modus X robotic exoscope, complementing system’s existing advanced fluorescence capabilities New Infrared fluorescence enables the use of Modus X for visualization of vessels in conjunction with indocyanine green New patented 4K ICG Image Fusion for real-time contrast of microsurgical vessels against background anatomy Synaptive Medical ...
-
Synaptive Medical Welcomes Chris Marrus as New Chief Commercial Officer
Synaptive Medical Inc., a global med tech and technology company solving surgical, imaging and data challenges, is proud to announce the appointment of Chris Marrus as Chief Commercial Officer. This appointment underscores Synaptive’s commitment to driving sales, expanding its market presence, and advancing innovative solutions in imaging and surgical technology focused on combining the ...
-
Synaptive’s Modus X Takes Center Stage in the latest issue of the Journal of Neurosurgery’s Neurosurgical Focus on exoscopes in neurosurgery
January’s Journal of Neurosurgery (JNS) published a series of 17 videos that examine the application of exoscopic visualization in cerebrovascular, neuro-oncologic, pediatric, peripheral nerve, and spinal neurosurgery. The video series highlights the exoscope as a versatile alternative to traditional optical microcopy. Seven of the videos highlight the use of Synaptive’s robotic ...
-
Synaptive Medical Introduces Cutting-Edge Modus X Robotic Exoscope in Europe with its First Imstallation at Azienda Ospedaliera Universitaria Federico ll in Naples, Italy
Synaptive Medical Inc., a global medical technology innovator, is pleased to announce the inaugural installation of its next-generation robotic exoscope, Modus X in Europe. This highly anticipated exoscope delivers a leap forward for surgical visualization in neurosurgery, ENT, plastics, and spine procedures, and it has made its European debut at Azienda Ospedaliera Universitaria Federico II in ...
-
Synaptive Medical Announces Timothy J. Scannell as New Chair of Board of Directors
Synaptive Medical, a global medical device and technology company solving surgical, imaging and data challenges, is pleased to announce the appointment of Timothy J. Scannell as the new Chair of the Board of Directors, effective June 20, 2023. Mr. Scannell joined Synaptive Medical’s Board of Directors in August 2022, bringing a wealth of experience and expertise in the medical device ...
-
New Surgical Images
As an organisation, we receive surgical images from a variety of specialities from surgeons all over the world. We are very grateful for this: it helps us to continuously develop medical devices designed for the need surgeons have, as well as confirming that the designs we have launched perform as intended. The images form a library of knowledge and education, and we have recently donated some ...
-
CD Bioparticles Launches NIR-Quantum Dots for Biomedical Imaging
With years of experience in the pharmaceutical and life science sector, CD Bioparticles launched a range of near-infra-red (NIR) quantum dots that exhibit excellent optical properties and biocompatibility for biomedical imaging. Currently, CD Bioparticles has successfully synthesized a variety of NIR quantum dots, including PbS/CdS, PbS, PbSe, Ag2S, CuInS/ZnS, and CdTe/CdSe/ZnS. Quantum points ...
-
1st Successful Heart Tumor Removal Without Open Heart Surgery
EchoPixel has once again contributed to a pioneering procedure at CentraCare – St. Cloud Hospital with the first team to remove a heart tumor without invasive open heart surgery using the novel AlphaVac catheter. Previously CentraCare had been the first to use EchoPixel’s 4D hologram technology to conduct the WATCHMAN implant, which is a one-time, minimally invasive procedure ...
-
ReShape Lifesciences Receives FDA 510(k) Clearance for the GIBI HD Calibration Tubes for use in Gastric and Bariatric Procedures
New Calibration Tubes, in Three Sizes, Will Simplify Gastric and Bariatric Procedures Including Laparoscopic Sleeve Gastrectomy, Gastric Bypass and Gastric Banding Company to Introduce Product at IFSO 2022 World Congress in August; Sales to Commence in September ReShape Lifesciences (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health solutions company, today announced ...
-
Onlume Receives FDA 510(k) Clearance for Fluorescence-guided Surgery Device
OnLume has received 510(k) clearance from the U.S. Food & Drug Administration (“FDA”) to market its first product, a fluorescence guided surgery (FGS) system. The OnLume Imaging System is indicated for fluorescence imaging of blood flow and tissue perfusion before, during, and after vascular, gastrointestinal, organ transplant, plastic, reconstructive, and micro surgeries. This ...
By OnLume Inc.
-
OnLume Surgical Awarded $2 Million Grant from National Cancer Institute to Advance the Development of its Novel Fluorescence-Guided Surgery Device
OnLume Inc., an early stage medical imaging company with unique technology for improving surgical precision, has been awarded a substantial grant from the U.S. National Institutes of Health (NIH)’s National Cancer Institute (NCI) to advance development of its proprietary device for Fluorescence-Guided Surgery (FGS). OnLume has developed novel FGS imaging technology to illuminate critical ...
By OnLume Inc.
-
OnLume Surgical Participates in Clinical Trial Combining Fluorescence-Guided Surgery Imaging Device with Alume’s Novel Nerve-Targeting Agent
OnLume Inc., a Madison, Wisconsin-based medical imaging company with unique technology for improving surgical precision in the operating room, has announced the start of participation in a clinical trial combining its fluorescence-guided surgery (FGS) imaging device with a novel nerve-targeting agent. OnLume has unique FGS imaging technology to illuminate critical anatomy in real time during ...
By OnLume Inc.
-
Lazurite™ Named One of the Industry’s Hottest Companies by World’s Largest MedTech Accelerator
MedTech Innovator, the world’s largest accelerator of medical technology companies, yesterday named Lazurite as one of the MedTech industry’s hottest 50 companies by selecting it to participate in Medtech Innovator’s flagship four-month Accelerator program featuring medical device, diagnostic, and digital health technologies from around the globe. As a 2022 Cohort member, ...
-
Activ Surgical Successfully Completes Institutional Review Board Study at University at Buffalo
BOSTON — May 24, 2022 — Activ Surgical™, a digital surgery pioneer, today announced the successful completion of an Institutional Review Board (IRB) study using its ActivSight™ intraoperative imaging module at the Jacobs School of Medicine and Biomedical Sciences at the University at Buffalo (UB) in New York. The 40-patient study was led by principal investigator Dr. ...
-
Stanford Physicians Continue to Rely on EchoPixel’s Technology
EchoPixel has had a long-standing relationship with Stanford physicians, who were early adopters of its technology, beginning with the successful surgery of the conjoined Sandoval twins in 2017. The affiliation has continued in partnership with Michael Ma, MD, Assistant Professor of Cardiothoracic Surgery in the Division of Pediatric Cardiac Surgery at Stanford University, who has used ...
-
Akrotome Co-Founder Makes International Presentations
Akrotome Co-Founder, Dr. Jim Basilion, traveled to Europe to make invited presentations in November, 2018. Dr. Basilion delivered papers focused on the use of molecular probes for guided, precision surgery to the European Society of Molecular Imaging, the World Society of Molecular Imaging, and the Netherlands Science ...
-
eCential Robotics boosts its platform technology with a surgical robotic arm
Gières (Grenoble), France, June 17, 2021 - eCential Robotics, a French growth company that designs, manufactures and markets the first unified 2D/3D robotic imaging and surgical navigation system for bone surgery indications, unveiled its surgical robotic arm as a world premiere at the annual meeting of the French Society of Spinal Surgery (SFCR), which is being held from June 17 to ...
-
Edinburgh Molecular Imaging and Mauna Kea Technologies Announce Clinical Molecular Imaging Collaboration
Edinburgh Molecular Imaging Ltd (EM Imaging) and Mauna Kea Technologies (Euronext: MKEA, OTCQX: MKEAY) today announced a clinical research collaboration to study the potential of combining EM Imaging’s in vivo optical imaging agents and Mauna Kea’s confocal laser endomicroscopy platform to diagnose cancer. The combination of novel molecular imaging agents and advanced visualisation ...
-
World`s First Use of Lightpoint Medical`s Robotic Gamma Probe in Lung Surgery Performed in the U.S.
Lightpoint Medical today announced that Dr. Doug Adams, a specialist in robotic thoracic surgery at Bethesda North Hospital (part of TriHealth, Ohio) performed a first-in-the-world lung procedure with SENSEI, the company's new miniature robotic gamma probe. SENSEI is smaller than an AA battery and designed specifically for robotic and minimally-invasive surgery. The miniature size and ...
-
Augmedics Announces FDA 510K Clearance and U.S. Launch of xvision, the First Augmented Reality Guidance System for Surgery
Augmedics, a pioneer in augmented reality surgical image guidance, has announced U.S. Food and Drug Administration (FDA) 510(k) clearance and the U.S. launch of its groundbreaking xvision Spine system (XVS), the first AR guidance system to be used in surgery. xvision Spine allows surgeons to visualize the 3D spinal anatomy of a patient during surgery as if they had “x-ray vision,” and ...
By Augmedics
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you